長時間作用型抗体は天然の抗体であり、すでにウイルスに感染している患者の治療や病気の進行を防ぐだけでなく、ウイルスにさらされる前の予防的介入として投与される可能性があります。市場は主に、治療用モノクローナル抗体市場の成長とCovid-19の現在のパンデミック状況によって牽引されています。PubMed.govによると、世界の治療用モノクローナル抗体市場は2018年に約1,152億米ドルと評価され、2019年末までに1,500億米ドルの収益を上げ、2025年までに3,000億米ドルを生み出すと予想されます。また、世界中で慢性疾患の割合が増加していることも、予測期間中の市場成長を高めると思われます。しかし、高い製造コストが2021年から2027年の予測期間における市場の成長を阻害しています。
世界の長時間作用型モノクローナル抗体市場の地域分析には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域が含まれます。北アメリカは、主要プレイヤーの存在と進行中の臨床試験により、市場シェアの点で世界の主要な地域となっており、アメリカは市場の主要プレイヤーとなっています。また、北アメリカは2021年から2027年の予測期間において、最も高い成長率/CAGRを示すと予測されています。医療インフラが整備され、病気の治療率が高いことなどが、アジア太平洋地域の長時間作用型モノクローナル抗体市場に有利な成長見通しをもたらすと思われます。
この調査の目的は、近年のさまざまなセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品提供の詳細な分析とともに、利害関係者が投資するミクロ市場での機会についても報告します。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. 1.2.1. Long-Acting Monoclonal Antibodies Market, by Region, 2019-2027 (USD Billion)
1.2.2. 1.2.1. Long-Acting Monoclonal Antibodies Market, by Source Type, 2019-2027 (USD Billion)
1.2.3. 1.2.1. Long-Acting Monoclonal Antibodies Market, by Indication, 2019-2027 (USD Billion)
1.2.4. 1.2.1. Long-Acting Monoclonal Antibodies Market, by End User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global 1.2.1. Long-Acting Monoclonal Antibodies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global 1.2.1. Long-Acting Monoclonal Antibodies Market Dynamics
3.1. 1.2.1. Long-Acting Monoclonal Antibodies Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing therapeutic monoclonal antibody market
3.1.1.2. Current Pandemic situation of Covid-19
3.1.2. Market Challenges
3.1.2.1. High Manufacturing cost
3.1.3. Market Opportunities
3.1.3.1. Rapid growth of chronic diseases
Chapter 4. Global 1.2.1. Long-Acting Monoclonal Antibodies Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, by Source Type
6.1. Market Snapshot
6.2. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by Source Type, Performance - Potential Analysis
6.3. Global 1.2.1. Long-Acting Monoclonal Antibodies Market Estimates & Forecasts by Source Type 2018-2027 (USD Billion)
6.4. 1.2.1. Long-Acting Monoclonal Antibodies Market, Sub Segment Analysis
6.4.1. Murine
6.4.2. Chimeric
6.4.3. Humanized
6.4.4. Human
Chapter 7. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, by Indication
7.1. Market Snapshot
7.2. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by Indication, Performance - Potential Analysis
7.3. Global 1.2.1. Long-Acting Monoclonal Antibodies Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
7.4. 1.2.1. Long-Acting Monoclonal Antibodies Market, Sub Segment Analysis
7.4.1. Cancer
7.4.2. Autoimmune Diseases
7.4.3. Inflammatory Diseases
7.4.4. Infectious Diseases
7.4.5. Others
Chapter 8. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, by End User
8.1. Market Snapshot
8.2. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by End User, Performance - Potential Analysis
8.3. Global 1.2.1. Long-Acting Monoclonal Antibodies Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
8.4. 1.2.1. Long-Acting Monoclonal Antibodies Market, Sub Segment Analysis
8.4.1. Hospitals Pharmacies
8.4.2. Drug Stores
8.4.3. Retail Pharmacies
8.4.4. E-commerce
Chapter 9. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, Regional Analysis
9.1. 1.2.1. Long-Acting Monoclonal Antibodies Market, Regional Market Snapshot
9.2. North America 1.2.1. Long-Acting Monoclonal Antibodies Market
9.2.1. U.S. 1.2.1. Long-Acting Monoclonal Antibodies Market
9.2.1.1. Source Type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Indication breakdown estimates & forecasts, 2018-2027
9.2.1.3. End User breakdown estimates & forecasts, 2018-2027
9.2.2. Canada 1.2.1. Long-Acting Monoclonal Antibodies Market
9.3. Europe 1.2.1. Long-Acting Monoclonal Antibodies Market Snapshot
9.3.1. U.K. 1.2.1. Long-Acting Monoclonal Antibodies Market
9.3.2. Germany 1.2.1. Long-Acting Monoclonal Antibodies Market
9.3.3. France 1.2.1. Long-Acting Monoclonal Antibodies Market
9.3.4. Spain 1.2.1. Long-Acting Monoclonal Antibodies Market
9.3.5. Italy 1.2.1. Long-Acting Monoclonal Antibodies Market
9.3.6. Rest of Europe 1.2.1. Long-Acting Monoclonal Antibodies Market
9.4. Asia-Pacific 1.2.1. Long-Acting Monoclonal Antibodies Market Snapshot
9.4.1. China 1.2.1. Long-Acting Monoclonal Antibodies Market
9.4.2. India 1.2.1. Long-Acting Monoclonal Antibodies Market
9.4.3. Japan 1.2.1. Long-Acting Monoclonal Antibodies Market
9.4.4. Australia 1.2.1. Long-Acting Monoclonal Antibodies Market
9.4.5. South Korea 1.2.1. Long-Acting Monoclonal Antibodies Market
9.4.6. Rest of Asia Pacific 1.2.1. Long-Acting Monoclonal Antibodies Market
9.5. Latin America 1.2.1. Long-Acting Monoclonal Antibodies Market Snapshot
9.5.1. Brazil 1.2.1. Long-Acting Monoclonal Antibodies Market
9.5.2. Mexico 1.2.1. Long-Acting Monoclonal Antibodies Market
9.6. Rest of The World 1.2.1. Long-Acting Monoclonal Antibodies Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Eli Lilly
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbott Laboratories
10.2.3. AstraZeneca plc
10.2.4. Amgen Inc.
10.2.5. Bayer AG
10.2.6. Johnson & Johnson
10.2.7. Pfizer
10.2.8. GlaxoSmithKline Plc.
10.2.9. Merck & Co. Inc.
10.2.10. Novartis
10.2.11. Research Process
10.3. Research Process
10.3.1. Data Mining
10.3.2. Analysis
10.3.3. Market Estimation
10.3.4. Validation
10.3.5. Publishing
10.4. Research Attributes
10.5. Research Assumption
LIST OF TABLES
TABLE 1. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, report scope
TABLE 2. Global 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by Region 2018-2027 (USD Billion)
TABLE 3. Global 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by Source Type 2018-2027 (USD Billion)
TABLE 4. Global 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by Indication 2018-2027 (USD Billion)
TABLE 5. Global 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by End User 2018-2027 (USD Billion)
TABLE 6. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. U.S. 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. U.S. 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 18. U.S. 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 19. Canada 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Canada 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 21. Canada 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 22. UK 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. UK 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. UK 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Germany 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Germany 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Germany 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. RoE 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. RoE 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. RoE 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. China 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. China 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. China 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. India 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. India 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. India 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Japan 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Japan 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Japan 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. RoAPAC 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. RoAPAC 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. RoAPAC 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Brazil 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. Brazil 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. Brazil 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. Mexico 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. Mexico 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. Mexico 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. RoLA 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. RoLA 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. RoLA 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Row 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Row 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Row 1.2.1. Long-Acting Monoclonal Antibodies Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global 1.2.1. Long-Acting Monoclonal Antibodies Market
TABLE 56. List of primary sources, used in the study of global 1.2.1. Long-Acting Monoclonal Antibodies Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
LIST OF FIGURES
FIG 1. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, research methodology
FIG 2. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, key trends 2020
FIG 5. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, growth prospects 2021-2027
FIG 6. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, porters 5 force model
FIG 7. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, pest analysis
FIG 8. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, value chain analysis
FIG 9. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global 1.2.1. Long-Acting Monoclonal Antibodies Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, regional snapshot 2018 & 2027
FIG 15. North America 1.2.1. Long-Acting Monoclonal Antibodies Market 2018 & 2027 (USD Billion)
FIG 16. Europe 1.2.1. Long-Acting Monoclonal Antibodies Market 2018 & 2027 (USD Billion)
FIG 17. Asia pacific 1.2.1. Long-Acting Monoclonal Antibodies Market 2018 & 2027 (USD Billion)
FIG 18. Latin America 1.2.1. Long-Acting Monoclonal Antibodies Market 2018 & 2027 (USD Billion)
FIG 19. Global 1.2.1. Long-Acting Monoclonal Antibodies Market, company market share analysis (2020)
